CRT 2026
Spotlight
Jeffrey W. Moses, MD, FSCAI
John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States
Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
Bernardo Cortese, MD, FESC, FSCAI
Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC
Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States
Disclosure information not submitted.
Tanveer Rab, MD, FACC, MSCAI
Professor
Emory University
Brookhaven, Georgia, United States
Disclosure(s): No financial relationships to disclose
Tarek Helmy, MD, FACC, MSCAI
Regional Chairman of the Cardiovascular Service Line
Trinity Health of New England
West Hartford, Connecticut, United States
Disclosure information not submitted.